Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis

The efficacy and safety of immune‐checkpoint inhibitors in non‐small cell lung cancer patients with idiopathic pulmonary fibrosis (IPF) remain unknown. Herein, we describe the case of a 62‐year‐old man with multiple pleural tumors and carcinomatous pleurisy. High‐resolution computed tomography indic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Maako, Tanaka, Kentaro, Sunami, Shunya, Asoh, Tatsuma, Maeyama, Takashige, Tsuruta, Nobuko, Nakanishi, Yoichi, Okamoto, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209776/
https://www.ncbi.nlm.nih.gov/pubmed/30152594
http://dx.doi.org/10.1111/1759-7714.12853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209776/
https://www.ncbi.nlm.nih.gov/pubmed/30152594
http://dx.doi.org/10.1111/1759-7714.12853

Ejemplares similares